Neoadjuvant Goserelin for Triple Negative Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer Triple Negative
Interventions: DRUG: Goserelin
Sponsor: Kasr El Aini Hospital